Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis

Excerpts from the publication

Background: Psilocybin, a naturally occurring psychedelic compound found in certain species of mushrooms, is known for its effects on anxiety and depression. It has recently gained increasing interest for its potential therapeutic effects, particularly in patients with advanced cancer. This systematic review and meta-analysis aim to evaluate the effects of psilocybin on adult patients with advanced cancer.

Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review

Ayahuasca’s therapeutic potential: What we know – and what not

Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

Long-Term Effects of Single and Repeated Ketamine Infusions on Treatment-Resistant Depression: A Retrospective Chart Review Study

Body mass index (BMI) does not predict responses to psilocybin